Veteran biotech journalist; delivers breaking industry news and analysis at STAT News.

Biotech investor; shares deep dives on biotech companies and investment strategies (often covering stocks he holds).

Sr. Business Editor, GEN/GEN Edge; biotech business

Senior biopharma correspondent, Endpoints

Biomedicine editor at MIT Technology Review; covers cutting-edge biotech breakthroughs and their societal impact.

Senior Editor, BioPharma Dive

Bloomberg’s markets channel; home to ETF IQ episodes; ETF trends/flows coverage.

Pseudonymous biotech insider; provides daily biotech news, startup financing updates, and trend analysis.

Biotech investor; creator of biotech stock indices and commentator on market trends.

Biotech venture capitalist (Atlas Venture); blogs as 'LifeSciVC' sharing startup trends and industry analysis.

STAT reporter-at-large on biopharma industry

Serial biotech entrepreneur; founded PureTech Health and co-founded Karuna Therapeutics, now CEO of Seaport Therapeutics.

Harvard/Broad Institute professor; pioneer of CRISPR gene editing (base and prime editing) driving biotech innovation.

Cardiologist and digital medicine researcher; leading voice on biotech and healthcare innovation.

Biostatistician; trial design/analysis, reproducible methods

Senior infectious disease reporter at STAT News; renowned for authoritative coverage of outbreaks, vaccines, and public health.

Biotech journalist (focus on oncology); provides sharp analysis of cancer drug data and industry developments.

Chair, Computational Biomedicine at Cedars-Sinai; AI/biostats

Co-founder & CEO of Ginkgo Bioworks; leading voice in synthetic biology and biotech entrepreneurship.

Veteran biotech journalist; founder of Endpoints News and known for insider industry insights.

Founder, SynBioBeta; community + events for synthetic biology

Academic health system; care delivery and innovation.

Author/editor (CRISPR, genomics); biotech education

Interviews and insights across pharma, biotech and medtech sectors.

Biotech journalist and author; founder of the Timmerman Report, offering deep industry coverage and analysis.

Senior biotech journalist at STAT News; covers drug development and the human stories behind the science.

Oncologist/clinical researcher; trial commentary

U.S. government’s medical research agency; features research advances, policy, and interviews across 27 institutes and centers.

The official YouTube presence of the journal Nature, featuring high-quality videos about cutting-edge scientific research. Many episodes highlight...

Gene therapy scientist; AAV and gene editing expert sharing lab breakthroughs and industry updates in advanced therapeutics.

Founder/CEO Flagship Pioneering; Co-founder/Chair, Moderna

Co-founder/CSO Aleta Biotherapeutics; I/O biology/CMC

Biotech investor/entrepreneur; small-cap biotech analysis

Japan’s PMDA training and regulatory updates (GCP/GLP/GMP, clinical trial and approval pathways).

Co-founder of ARCH Venture Partners; influential biotech VC behind numerous startups and known for bold industry bets.

Oncology consultant and blogger; author of PharmaStrategy Blog known for insightful analysis of cancer drug development.

Physician and former FDA Commissioner; influential voice on biotech regulation and public health (board member at Pfizer &...

Co-founder & CEO, Octant Bio; multiplexed drug discovery

Academic medicine; innovation, care delivery, outcomes.

Biopharma/medtech policy and industry news, explainers, interviews.

Narrated features and news roundups from Drug Discovery World covering discovery, development, enabling tech, and industry trends.

Authoritative insight on politics, business & finance.

Official FDA channel covering regulatory science, approvals, safety, and industry guidance (CDER/CBER content, SBIA, Grand Rounds).

Global health systems, regulations, and policy.

Live market coverage and interviews on rates, currencies, and macro investing.

Sr. Editor, Endpoints; FDA/Capitol Hill/biopharma